11-101-3771

Naproxen sodium Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™

Manufacturer: MilliporeSigma Supelco

CAS Number: 26159-34-2

Select a Size

Pack Size SKU Availability Price
Each of 1 11-101-3771-Each-of-1 In Stock ₹ 14,507.00

11-101-3771 - Each of 1

₹ 14,507.00

In Stock

Quantity

1

Base Price: ₹ 14,507.00

GST (18%): ₹ 2,611.26

Total Price: ₹ 17,118.26

CAS

26159-34-2

Type

Certified Reference Material

Linear Formula

C14H13 NaO3

Synonym

(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid sodium salt

Grade

Certified Reference Material

Quantity

1 g

Purity Grade Notes

These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available.

MDL Number

MFCD00058507

Formula Weight

252.24

Physical Form

Neat

Other Options

Image Product Name Manufacturer Price Range
50-115-2466
Apexbio Technology LLC adenylate cyclase regulator. N6-methyladenosine (m6A) 500mg. 26159-34-2. MFCD00058507
Apexbio Technology LLC ₹ 13,350.00
NC2156795
U.S. Pharmacopeia naproxen sodium | 26159-34-2 | 252.24 g/mol | 200 MG
U.S. Pharmacopeia ₹ 30,854.52
50-179-3337
Sigma Aldrich Fine Chemicals Biosciences Naproxen sodium meets USP testing specifications | 26159-34-2 | MFCD00058507 | 5G
Sigma Aldrich Fine Chemicals Biosciences ₹ 12,320.27
PHR1165
Naproxen sodium
Supelco ₹ 11,994.10
CS-2162
Naproxen sodium
ChemScene ₹ 4,450.00 - ₹ 8,544.00
AI46064
26159-34-2 | sodium (2S)-2-(6-methoxynaphthalen-2-yl)propanoate
A2B Chem ₹ 445.00 - ₹ 18,601.00

Related Products

Img

MilliporeSigma Supelco

11-101-9626

--

Img

MilliporeSigma Supelco

11-101-9312

--

Img

MilliporeSigma Supelco

11-101-2786

--

Img

MilliporeSigma Supelco

11-101-4696

--

Img

MilliporeSigma Supelco

11-101-4829

--

Img

MilliporeSigma Supelco

11-101-9310

--

Img

MilliporeSigma Supelco

11-101-4407

--

Img

MilliporeSigma Supelco

11-101-3014

--

Description

  • Naproxen sodium (NS) is a sodium salt of propionic acid derivative and demonstrates analgesic, anti-pyretic, and anti-inflammatory properties
  • It exhibits efficiency in being used as an indomethacin in the treatment of acute musculoskeletal disorders
  • It belongs to the group of nonsteroidal anti-inflammatory drugs (NSAIDS) and acts by inhibiting the activity of both the cyclooxygenase enzymes, COX-1 & COX-2 and further blocking the synthesis of certain prostaglandins
  • It is administered in the treatment of ankylosing spondylitis, osteoarthritis, rheumatoid disorders, acute gout, mild to moderate pain, tendonitis, bursitis, dysmenorrhea, fever, and migraine headache
  • Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.